Concord Wealth Partners Seres Therapeutics, Inc. Transaction History

Concord Wealth Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$6.02 - $11.43 $319 - $605	-53 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$5.46 - $22.6 $682 - $2,825	-125 Reduced 70.22%	53 $0
Q2 2021 Jul 29, 2021	SELL	$18.46 - $24.36 $7,384 - $9,744	-400 Reduced 69.2%	178 $4,000
Q1 2021 May 13, 2021	BUY	$17.66 - $28.92 $8,918 - $14,604	505 Added 691.78%	578 $12,000
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $1,697 - $2,754	73 New	73 $2,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $86.9M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.